Genistein (4,7,4’-trihydroxy-isoflavone) hampers B16-F10 tumor growth by dose-dependently cytotoxic T-cell activity, IL-2-stimulated NK activity, and basal splenocyte proliferation [168]. This evidence concerns the gene IL2 and neoplasm.